demonstrated a highly significant association between the BRAF V600E mutation and KMT2A gene rearrangement in therapy-related AML based on three cases [ 5 ].
← all excerpts
<i>BRAF</i> Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience.
1
—
—